Ah, finals week is upon us, and, in honor of finals, here’s a poem before we dive into testing advice for specific academic subjects. Students with knowledge all stuck in their heads, hardly sleeping or lying in their own beds. Not a student was resting, not even the profs, all hoped finals would be over... Continue Reading →
Bullish Dancing with Jazz Pharmaceuticals (written October 2012) (P.S. I was right.)
With Jazz Pharmaceuticals’ (NASDAQ: JAZZ) remarkable share price increase from a 52-week low of $34.02 to a recent high of $60.00, it makes you wonder how much gas JAZZ has left in the tank. A biopharmaceutical company based in Ireland, JAZZ produces sixteen different medications pertaining to narcolepsy, pain management, oncology, psychiatry, and women’s health.... Continue Reading →